{"id":156573,"date":"2023-11-22T07:31:52","date_gmt":"2023-11-22T12:31:52","guid":{"rendered":"https:\/\/44.250.171.167\/?p=156573"},"modified":"2023-11-22T07:31:53","modified_gmt":"2023-11-22T12:31:53","slug":"orchid-pharma-ltd-q2fy24-21-rise-in-revenue","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/orchid-pharma-ltd-q2fy24-21-rise-in-revenue\/","title":{"rendered":"Orchid Pharma Ltd Q2FY24; 21% rise in Revenue"},"content":{"rendered":"<p>Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.<\/p>\n<p>Financial Results:<\/p>\n<ul>\n<li>Orchid Pharma Ltd reported Revenues for Q2FY24 of \u20b9199.00 Crores up from \u20b9165.00 Crore year on year, a rise of 20.61%.<\/li>\n<li>Total Expenses for Q2FY24 of \u20b9187.00 Crores up from \u20b9174.00 Crores year on year, a rise of 7.47%.<\/li>\n<li>Consolidated Net Profit of \u20b920.00 Crores from -\u20b95.00 Crores in the same quarter of the previous year.<\/li>\n<li>The Earnings per Share is \u20b93.90, from -\u20b91.32 in the same quarter of the previous year.<\/li>\n<\/ul>\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294-839x1024.png\" alt=\"\" class=\"wp-image-156574\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/ASAI-Product-2-5.gif\" alt=\"\" class=\"wp-image-156437\" width=\"435\" height=\"161\"\/><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd reported Revenues for Q2FY24 of \u20b9199.00 Crores up from \u20b9165.00 Crore year on year, a rise of 20.61%. Total Expenses [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[9138],"class_list":["post-156573","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-pharma"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":145782,"url":"https:\/\/alphastreet.com\/india\/orchid-pharma-limited-q4fy23-earnings-story\/","url_meta":{"origin":156573,"position":0},"title":"Orchid Pharma Limited Q4FY23 Earnings Story","author":"Karan_Singh","date":"May 11, 2023","format":false,"excerpt":"Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd. reported Total Income for Q4FY23 of \u20b9 212 Crores up from \u20b9 180 Crore year\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":152674,"url":"https:\/\/alphastreet.com\/india\/orchid-pharma-ltd-q1fy24-40-rise-in-revenue\/","url_meta":{"origin":156573,"position":1},"title":"Orchid Pharma Ltd Q1FY24; 40% rise in Revenue","author":"Karan_Singh","date":"August 10, 2023","format":false,"excerpt":"Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd reported Revenues for Q1FY24 of \u20b9182.92 Crores up from \u20b9130.99 Crore year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157069,"url":"https:\/\/alphastreet.com\/india\/aurobindo-pharma-ltd-q2fy24-83-rise-in-profits\/","url_meta":{"origin":156573,"position":2},"title":"Aurobindo Pharma Ltd Q2FY24; 83% rise in Profits","author":"Divyansh_Kasana","date":"December 4, 2023","format":false,"excerpt":"Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. Financial Results: Aurobindo Pharma Ltd reported Revenues for Q2FY24 of \u20b97,219.00 Crores up from \u20b95,739.00 Crore year on year, a rise of 25.79%. Total Expenses for Q2FY24 of \u20b96,332.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-25.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":155773,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q2fy24-24-rise-in-profits\/","url_meta":{"origin":156573,"position":3},"title":"Ajanta Pharma Ltd Q2FY24; 24% rise in Profits","author":"Divyansh_Kasana","date":"November 6, 2023","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported Revenues for Q2FY24 of \u20b91,028.00 Crores up from \u20b9938.00 Crore year on year, a rise of 9.59%. Total Expenses for Q2FY24 of \u20b9774.00 Crores down from \u20b9776.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-63.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157083,"url":"https:\/\/alphastreet.com\/india\/astrazeneca-pharma-india-ltd-q2fy24-58-rise-in-profits\/","url_meta":{"origin":156573,"position":4},"title":"Astrazeneca Pharma India Ltd Q2FY24; 58% rise in Profits","author":"Divyansh_Kasana","date":"December 4, 2023","format":false,"excerpt":"AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India Ltd reported Revenues for Q2FY24 of \u20b9311.00 Crores up from \u20b9236.00 Crore year on year, a rise of 31.78%. Total Expenses for Q2FY24 of \u20b9262.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-27.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-27.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-27.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-27.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-27.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-27.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157279,"url":"https:\/\/alphastreet.com\/india\/solara-active-pharma-sciences-ltd-q2fy24-26-rise-in-revenue\/","url_meta":{"origin":156573,"position":5},"title":"Solara Active Pharma Sciences Ltd Q2FY24; 26% rise in Revenue","author":"Chirag Gupta","date":"December 12, 2023","format":false,"excerpt":"Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs. Financial Results: Solara Active Pharma Sciences Ltd reported Revenues for Q2FY24 of \u20b9425.00 Crores up from \u20b9338.00 Crore year on year, a rise of 25.74%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-88.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/156573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=156573"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/156573\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=156573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=156573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=156573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}